Samik Pharm. (014950.KQ) stock: key figures, P/E, revenue and dividend

Health Care · South Korea · ISIN KR7014950000

Price
7,200.00 KRW
Market cap
66.03 bn KRW
P/E (2025)
–
P/S (2025)
1.10
Dividend yield
0.56 %
Net margin
-1.26 %
Return on equity (ROE)
-1.09 %
Return on assets (ROA)
-0.89 %

Samik Pharm. financials

Fiscal year20242025
Revenue–60.02 bn KRW
Gross profit–42.36 bn KRW
Operating income3.68 bn KRW3.27 bn KRW
EBIT–77.74 m KRW
Net income3.52 bn KRW-754.89 m KRW
Diluted EPS – continuing operations–-82.31 KRW

Full history since 2024, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Samik Pharm.

Samik Pharmaceutical Company LTD. develops and manufactures pharmaceuticals. The company offers oral therapeutic pharmaceuticals. It also provides drug compounds, drug delivery systems, drug repositioning, and reinforcement of biopharmaceuticals. The company was founded in 1973 and is based in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.